Nanobiotix S.A. ADR NBTX 深 滬
等待開盤 09-10 09:30:00 美东时间
9.1421
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 9.1421
- 總市值 4.33亿
- 52周最高 10.59
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.76
- 委 比 0.00%
- 總股本 4740.47万
- 歷史最高 21.55
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.75
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nanobiotix to Present at H.C. Wainwright Investment Conference
Nanobiotix ( ($NBTX) ) has shared an update. On September 2, 2025, Nanobiotix a...
09-03 04:49
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
Nautilus Biotechnology, Inc. will participate in two investor conferences: Morgan Stanley's Global Healthcare Conference on September 8 and the Q3 Investor Summit Group Virtual Conference on September 16. Access live webcasts on their website at www.nautilus.bio.
08-27 12:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
SelectQuote Posts Better-Than-Expected Results, Joins Nutex Health, NIO, MINISO Group And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
08-21 23:32
Nanobiotix Advances JNJ-1900 with Regulatory and Patent Milestones
Nanobiotix ( ($NBTX) ) just unveiled an announcement. On July 7, 2025, Nanobiot...
07-12 05:27
Nanobiotix Allocates Free Shares to Executives
An update from Nanobiotix ( ($NBTX) ) is now available. Nanobiotix, a company i...
07-02 23:07
Voting Rights and Shares Capital of the Company
Nanobiotix, a late-stage clinical biotechnology company, announced updates on its share capital and voting rights as of May 31, 2025. The company, listed on Euronext Paris and Nasdaq, reported 47,426,851 outstanding shares and theoretical voting rights totaling 49,529,244, with 49,507,126 exercisable. Nanobiotix, headquartered in Paris, has developed over 25 patent families across three nanotechnology platforms addressing oncology, bioavailabilit...
06-10 20:15
Nanobiotix Sa ADR Reports Q1 2025 Progress
Nanobiotix Sa ADR ( ($NBTX) ) has released its Q1 earnings. Here is a breakdown...
06-06 11:51
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
Nanobiotix, a late-clinical stage biotechnology company, announced that its management will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 3:45 pm EDT. The event will be webcast live and available for replay. Nanobiotix, headquartered in Paris with subsidiaries in Cambridge, Massachusetts, focuses on nanoparticle-based therapies for cancer and other diseases. The company has over 25 patents across...
05-28 06:00
Nanobiotix Provides Q1 2025 Operational Update; Says It Anticipates That The Cash And Cash Equivalents Of €39.8 Million As Of March 31, 2025, Will Fund Its Operations Into Mid-2026
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancerPresentation of data at the European Lung Cancer Conference
05-22 04:18
